News

NYU Langone Joins NIH’s Quest for Sjögren’s Treatments

NYU Langone Health is joining with a National Institutes of Health (NIH) sponsored program aimed at understanding disease mechanisms and developing new treatments for autoimmune disorders such as Sjögren’s syndrome. The program, called Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases (AMP AIM), began last year in an…